A new B cell differentiation antigen (BDA) on normal and leukemic human B lymphocytes that is distinct from known DR (Ia-like) antigens
Balch, C.M.; Dougherty, P.A.; Vogler, L.B.; Ades, E.W.; Ferrone, S.
Journal of Immunology 121(6): 2322-2328
1978
ISSN/ISBN: 0022-1767 PMID: 102693 Document Number: 129711
A newly defined human B cell differentiation antigen, designated as BDA, has been defined and partially characterized. BDA is expressed on normal human B cells and lymphocytic leukemia cells at all stages of known differentiation (pre-B cells to plasma cells). It is distinct from DR (Ia-like) determinants and other known B cell surface constituents.
Document emailed within 1 workday
Related Documents
Radzikowski, C. 1978: Studies on cell surface antigens of mouse leukemic and normal lymphocytes. I. Categories of cell surface antigens on mouse leukemia and their serological identification Archivum Immunologiae et Therapiae Experimentalis 26(1-6): 89-93Teeuwsen, V.J.; Logtenberg, T.; Siebelink, K.H.; Lange, J.M.; Goudsmit, J.; Uytdehaag, F.G.; Osterhaus, A.D. 1987: Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation Journal of Immunology 139(9): 2929-2935
Clement, L.T.; Yamashita, N.; Martin, A.M. 1988: The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation Journal of Immunology 141(5): 1464-1470
Fox, R.I.; Harlow, D.; Royston, I.; Elder, J. 1982: Structural characterization of the human T cell surface antigen (p67) isolated from normal and neoplastic lymphocytes Journal of Immunology 129(1): 401-405
Nojiri, H.; Takaku, F.; Ohta, M.; Miura, Y.; Saito, M. 1985: Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60 Cancer Research 45(12 Pt 1): 6100-6106
Seon, B.K.; Yoshizaki, K.; Pressman, D. 1979: Detection and characterization of human leukemia-associated antigens on leukemic cell lines and thymocytes. II. Isolation of human thymus-leukemia-associated antigens from the cell surface and partial characterization Journal of Immunology 122(5): 1951-1959
Kuritani, T.; Negoro, S.; Kishimoto, S. 1988: CD antigens and the differentiation of human lymphocytes Human Cell 1(3): 282-288
Raĭtsina, S.S.; Kalinina, I.I. 1979: Ultrastructure and antigens in differentiation of thymus lymphocytes in human embryogenesis Biulleten' Eksperimental'noi Biologii i Meditsiny 88(10): 470-473
Baryshnikov, A.I. 1990: Monoclonal antibodies of the ICO series against differentiation antigens of human lymphocytes Gematologiia i Transfuziologiia 35(8): 4-7
Hassan, H.T.; Rees, J.K. 1990: Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line Folia Haematologica 117(1): 151-159
Carpentieri, U.; Kalmaz, G.; Ezell, E.; Thorpe, L.W. 1988: Trace metals, surface receptors and growth of human normal and leukemic lymphocytes Anticancer Research 8(6): 1393-1397
Koeffler, H.P.; Amatruda, T.; Ikekawa, N.; Kobayashi, Y.; Deluca, H.F. 1984: Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues Cancer Research 44(12 Pt 1): 5624-5628
Catena, C.; Mattoni, A. 1985: Damage to DNA by tritiated thymidine and its development in normal human (PHA-stimulated lymphocytes) and leukemic (Molt-3) lymphoblasts Bollettino della Societa Italiana di Biologia Sperimentale 61(7): 1075-1081
Nagai, M.; Natsumeda, Y.; Weber, G. 1992: Proliferation-linked regulation of type Ii IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells Cancer Research 52(2): 258-261
Carpentieri, U.; Minguell, J.J.; Haggard, M.E. 1980: Variation of activity of protein kinases in unstimulated and phytohemagglutinin-stimulated normal and leukemic human lymphocytes Cancer Research 40(8 Part 1): 2714-2718
Oblender, M.; Carpentieri, U. 1990: Effects of iron, copper and zinc on the activity of ribonucleotide reductase in normal and leukemic human lymphocytes Anticancer Research 10(1): 123-127
Wahren, B.; Gahrton, G.; Hammarström, S. 1980: Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients Cancer Research 40(6): 2039-2044
Nadler, L.M.; Stashenko, P.; Hardy, R.; van Agthoven, A.; Terhorst, C.; Schlossman, S.F. 1981: Characterization of a human B cell-specific antigen (B2) distinct from B1 Journal of Immunology 126(5): 1941-1947
Miyoshi, I.; Kubonishi, I.; Yoshimoto, S.; Shiraishi, Y. 1981: A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells Gan 72(6): 978-981
Gabbianelli, M.; Valtieri, M.; Peschle, C. 1991: The human hematopoietic stem cell, normal and leukemic Haematologica 76(Suppl 3): 293-302